BCL-2 Translocation
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Rearranged HGBL (NCT03620578) | Stichting Hemato-Oncologie voor Volwassenen Nederland | 2018-08-01 |
Track BCL-2 Translocation automatically
Every clearance here is in the API, with alerts when new ones post.